product summary
Loading...
company name :
R&D Systems
product type :
protein
product name :
Universal Type I IFN Protein
catalog :
11200-1
quantity :
100000 UN
price :
562 USD
more info or order :
citations: 30
Reference
Song J, Chow R, Pe xf1 a Hern xe1 ndez M, Zhang L, Loeb S, So E, et al. LRRC15 inhibits SARS-CoV-2 cellular entry in trans. PLoS Biol. 2022;20:e3001805 pubmed publisher
Los B, Preu xdf ner M, Eschke K, Vidal R, Abdelgawad A, Olofsson D, et al. Body temperature variation controls pre-mRNA processing and transcription of antiviral genes and SARS-CoV-2 replication. Nucleic Acids Res. 2022;50:6769-6785 pubmed publisher
Yang X, Zhao X, Zhu Y, Shen Y, Wang Y, Lu P, et al. FKBP3 Induces Human Immunodeficiency Virus Type 1 Latency by Recruiting Histone Deacetylase 1/2 to the Viral Long Terminal Repeat. MBio. 2021;:e0079521 pubmed publisher
Buang N, Tapeng L, Gray V, Sardini A, Whilding C, Lightstone L, et al. Type I interferons affect the metabolic fitness of CD8+ T cells from patients with systemic lupus erythematosus. Nat Commun. 2021;12:1980 pubmed publisher
Singh K, Zerbato J, Zhao W, Braat S, Deléage C, Tennakoon G, et al. Intrahepatic CXCL10 is strongly associated with liver fibrosis in HIV-Hepatitis B co-infection. PLoS Pathog. 2020;16:e1008744 pubmed publisher
Paulus C, Harwardt T, Walter B, Marxreiter A, Zenger M, Reuschel E, et al. Revisiting promyelocytic leukemia protein targeting by human cytomegalovirus immediate-early protein 1. PLoS Pathog. 2020;16:e1008537 pubmed publisher
van der Sluis R, Zerbato J, Rhodes J, Pascoe R, Solomon A, Kumar N, et al. Diverse effects of interferon alpha on the establishment and reversal of HIV latency. PLoS Pathog. 2020;16:e1008151 pubmed publisher
Kuca Warnawin E, Skalska U, Janicka I, Musiałowicz U, Bonek K, Głuszko P, et al. The Phenotype and Secretory Activity of Adipose-Derived Mesenchymal Stem Cells (ASCs) of Patients with Rheumatic Diseases. Cells. 2019;8: pubmed publisher
Vahedi F, Lee A, Collins S, Chew M, Lusty E, Chen B, et al. IL-15 and IFN-? signal through the ERK pathway to inhibit HCV replication, independent of type I IFN signaling. Cytokine. 2018;: pubmed publisher
Matsuno K, Kajihara M, Nakao R, Nao N, Mori Kajihara A, Muramatsu M, et al. The Unique Phylogenetic Position of a Novel Tick-Borne Phlebovirus Ensures an Ixodid Origin of the Genus Phlebovirus. mSphere. 2018;3: pubmed publisher
Cytlak U, Resteu A, Bogaert D, Kuehn H, Altmann T, Gennery A, et al. Ikaros family zinc finger 1 regulates dendritic cell development and function in humans. Nat Commun. 2018;9:1239 pubmed publisher
Dai X, Tohyama M, Murakami M, Sayama K. Epidermal keratinocytes sense dsRNA via the NLRP3 inflammasome, mediating interleukin (IL)-1β and IL-18 release. Exp Dermatol. 2017;26:904-911 pubmed publisher
Chen Q, Boire A, Jin X, Valiente M, Er E, Lopez Soto A, et al. Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer. Nature. 2016;533:493-498 pubmed publisher
Hedges J, Robison A, Kimmel E, Christensen K, Lucas E, Ramstead A, et al. Type I Interferon Counters or Promotes Coxiella burnetii Replication Dependent on Tissue. Infect Immun. 2016;84:1815-1825 pubmed publisher
Labzin L, Schmidt S, Masters S, Beyer M, Krebs W, Klee K, et al. ATF3 Is a Key Regulator of Macrophage IFN Responses. J Immunol. 2015;195:4446-55 pubmed publisher
Berri F, Haffar G, Lê V, Sadewasser A, Paki K, Lina B, et al. Annexin V incorporated into influenza virus particles inhibits gamma interferon signaling and promotes viral replication. J Virol. 2014;88:11215-28 pubmed publisher
Cimica V, Dalrymple N, Roth E, Nasonov A, Mackow E. An innate immunity-regulating virulence determinant is uniquely encoded by the Andes virus nucleocapsid protein. MBio. 2014;5: pubmed publisher
Ray A, Tian Z, Das D, Coffman R, Richardson P, Chauhan D, et al. A novel TLR-9 agonist C792 inhibits plasmacytoid dendritic cell-induced myeloma cell growth and enhance cytotoxicity of bortezomib. Leukemia. 2014;28:1716-24 pubmed publisher
Li X, Jiang L, Chen L, Ding M, Guo H, Zhang W, et al. RIG-I modulates Src-mediated AKT activation to restrain leukemic stemness. Mol Cell. 2014;53:407-19 pubmed publisher
Li W, Okuda A, Yamamoto H, Yamanishi K, Terada N, Yamanishi H, et al. Regulation of development of CD56 bright CD11c + NK-like cells with helper function by IL-18. PLoS ONE. 2013;8:e82586 pubmed publisher
Wang T, Ge Y, Xiao M, Lopez Coral A, Li L, Roesch A, et al. SECTM1 produced by tumor cells attracts human monocytes via CD7-mediated activation of the PI3K pathway. J Invest Dermatol. 2014;134:1108-1118 pubmed publisher
Webster B, Ott M, Greene W. Evasion of superinfection exclusion and elimination of primary viral RNA by an adapted strain of hepatitis C virus. J Virol. 2013;87:13354-69 pubmed publisher
Chen Q, Swaminathan S, Yang D, Dai L, Sui H, Yang J, et al. Interleukin-27 is a potent inhibitor of cis HIV-1 replication in monocyte-derived dendritic cells via a type I interferon-independent pathway. PLoS ONE. 2013;8:e59194 pubmed publisher
Rosen L, Freeman A, Yang L, Jutivorakool K, Olivier K, Angkasekwinai N, et al. Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis. J Immunol. 2013;190:3959-66 pubmed publisher
Srivastava R, Lee S, Andrade Filho P, Lord C, Jie H, Davidson H, et al. Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients. Clin Cancer Res. 2013;19:1858-72 pubmed publisher
Jones P, Maric M, Madison M, Maury W, Roller R, Okeoma C. BST-2/tetherin-mediated restriction of chikungunya (CHIKV) VLP budding is counteracted by CHIKV non-structural protein 1 (nsP1). Virology. 2013;438:37-49 pubmed publisher
Wilson T, Fridlyand J, Yan Y, Penuel E, Burton L, Chan E, et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature. 2012;487:505-9 pubmed publisher
Cilloniz C, Pantin Jackwood M, Ni C, Carter V, Korth M, Swayne D, et al. Molecular signatures associated with Mx1-mediated resistance to highly pathogenic influenza virus infection: mechanisms of survival. J Virol. 2012;86:2437-46 pubmed publisher
Knoblach T, Grandel B, Seiler J, Nevels M, Paulus C. Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell response that depends on activated STAT1 but not interferon-?. PLoS Pathog. 2011;7:e1002016 pubmed publisher
Albanesi C, Scarponi C, Pallotta S, Daniele R, Bosisio D, Madonna S, et al. Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J Exp Med. 2009;206:249-58 pubmed publisher
product information
master code :
11200-1
SKU :
11200-1
product name :
Universal Type I IFN Protein
unit size :
100000 UN
description :
The Universal Type I IFN Protein from R&D Systems is derived from E. coli.
target :
IFN-alpha
category :
Proteins and Enzymes
conjugate :
Unconjugated
species :
Human
gene symbol :
IFNA2
source short :
E. coli
USD :
562 USD
alt names :
IFNA, IFNA2, IFNA2b, IFNalpha, IFN-alphaA, INFA2, interferon alpha 2, LeIF D
storage :
Store the unopened product at -20 to -70 ░C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.